NCT06121700
- Conditions
- Adenocarcinoma, Adenocarcinoma of the Stomach, Carcinoma, +21 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
Clinical trial condition
Oligometastatic Disease
Explore clinical trials studying Oligometastatic Disease. Study availability and eligibility vary by location and protocol.
37 public trials
22 recruiting studies
Oligometastatic Disease trial results
Recruiting
Phase 2 Study of SBRT Plus Tislelizumab and Regorafenib in Unresectable or Oligometastatic HCC
NCT05917431
- Conditions
- Oligometastatic Disease, Unresectable Hepatocellular Carcinoma
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
Not yet recruiting
Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma
NCT07824856
- Conditions
- Ablation Techniques, Carcinoma, Head and Neck Neoplasms, +19 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Not yet recruiting
MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial).
NCT07593261
- Conditions
- Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
- Gemelli ART (Advanced Radiation Therapy)-Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy
Not yet recruiting
125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer
NCT07333651
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
- Locations
-
- The 960th Hospital of People's Liberation Army (PLA) Jinan, Shandong, China
NCT06842030
- Conditions
- Feasibility, Oligometastatic Disease, Personalized Medicine
- Locations
-
- Good Samaritan University Hospital West Islip, New York, United States
Not yet recruiting
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study
NCT06430411
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +13 more
- Locations
-
Not specified
Active, not recruiting
Local Ablative Radiotherapy for OLIgoprogressive Castration Resistant Prostate Cancer
NCT04141709
- Conditions
- Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
- Locations
-
- Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden Dresden, Saxony, Germany
- University Medical Center Freiburg, Department of Radiation Oncology Freiburg im Breisgau, Germany
- University Hospital Heidelberg, Department of Radiation Oncology Heidelberg, Germany
- University Clinic Tübingen, Clinic for Radiation Oncology Tübingen, Germany
Active, not recruiting
Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
NCT04748042
- Conditions
- Castrate Sensitive Prostate Cancer, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
Active, not recruiting
RESOLUTE Trial Aims to Investigate the Value of Adding Local Ablative Treatment to Standard Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer
NCT05862051
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +10 more
- Locations
-
- Border Medical Oncology Albury, New South Wales, Australia
- Bendigo Hospital Bendigo, Victoria, Australia
- Eastern Health Box Hill, Victoria, Australia
- The Northern Hospital Epping, Victoria, Australia